Cargando…

The Impact of Angiogenesis in the Most Common Salivary Gland Malignant Tumors

Salivary gland carcinomas (SGCs) represent a group of rare tumors, with complete surgical resection being the main treatment option. Therapeutic armory for cases of locally aggressive, recurrent, and/or metastatic SGCs, though, remains poor since they exhibit high rates of resistance to systematic t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pouloudi, Despoina, Sotiriadis, Aristoteles, Theodorakidou, Margarita, Sarantis, Panagiotis, Pergaris, Alexandros, Karamouzis, Michalis V., Theocharis, Stamatios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762607/ https://www.ncbi.nlm.nih.gov/pubmed/33302367 http://dx.doi.org/10.3390/ijms21249335

Ejemplares similares

Clinical Significance of Histone Deacetylase (HDAC)-1, -2, -4 and -6 Expression in Salivary Gland Tumors
por: Pouloudi, Despoina, et al.
Publicado: (2021)

HuR Protein in Hepatocellular Carcinoma: Implications in Development, Prognosis and Treatment
por: Papatheofani, Vasiliki, et al.
Publicado: (2021)

The Controversial Role of Autophagy in Ewing Sarcoma Pathogenesis—Current Treatment Options
por: Koustas, Evangelos, et al.
Publicado: (2021)

Unusual Presentation of an Uncommon Malignancy: A 74-Year-Old Woman with Aggressive Fibromatosis of the Large Intestine Presenting as a Liver Mass and the Therapeutic Management
por: Vallilas, Christos, et al.
Publicado: (2023)

Gastrointestinal Stromal Tumors (GISTs): Novel Therapeutic Strategies with Immunotherapy and Small Molecules
por: Vallilas, Christos, et al.
Publicado: (2021)

Combinatorial Treatment of Tinzaparin and Chemotherapy Can Induce a Significant Antitumor Effect in Pancreatic Cancer
por: Sarantis, Panagiotis, et al.
Publicado: (2021)

Combining RANK/RANKL and ERBB-2 targeting as a novel strategy in ERBB-2-positive breast carcinomas
por: Zoi, Ilianna, et al.
Publicado: (2019)

Challenging, Accurate and Feasible: CAF-1 as a Tumour Proliferation Marker of Diagnostic and Prognostic Value
por: Sykaras, Alexandros G., et al.
Publicado: (2021)

Ephrin Receptors (Ephs) Expression in Thymic Epithelial Tumors: Prognostic Implications and Future Therapeutic Approaches
por: Masaoutis, Christos, et al.
Publicado: (2021)

Extracellular Vesicles as Biomarkers Carriers in Bladder Cancer: Diagnosis, Surveillance, and Treatment
por: Georgantzoglou, Natalia, et al.
Publicado: (2021)

Histone Deacetylase Inhibitors: A Promising Therapeutic Alternative for Endometrial Carcinoma
por: Psilopatis, Iason, et al.
Publicado: (2021)

Utilizing Exosomal-EPHs/Ephrins as Biomarkers and as a Potential Platform for Targeted Delivery of Therapeutic Exosomes
por: Goutas, Dimitrios, et al.
Publicado: (2022)

High Pregnane X Receptor (PXR) Expression Is Correlated with Poor Prognosis in Invasive Breast Carcinoma
por: Theocharis, Stamatios, et al.
Publicado: (2021)

EPHA2, EPHA4, and EPHA7 Expression in Triple-Negative Breast Cancer
por: Nikas, Ilias, et al.
Publicado: (2022)

The EPH/Ephrin System in Colorectal Cancer
por: Papadakos, Stavros P., et al.
Publicado: (2022)

Mechanisms of the Antitumor Activity of Low Molecular Weight Heparins in Pancreatic Adenocarcinomas
por: Bokas, Alexandros, et al.
Publicado: (2020)

Thymic Epithelial Neoplasms: Focusing on the Epigenetic Alterations
por: Psilopatis, Iason, et al.
Publicado: (2022)

The EPH/Ephrin System in Gynecological Cancers: Focusing on the Roots of Carcinogenesis for Better Patient Management
por: Psilopatis, Iason, et al.
Publicado: (2022)

The Role of PROX1 in Neoplasia: A Key Player Often Overlooked
por: Ntikoudi, Evangelia, et al.
Publicado: (2022)

Pregnane X Receptor (PXR) Polymorphisms and Cancer Treatment
por: Skandalaki, Aikaterini, et al.
Publicado: (2021)

Upgraded role of autophagy in colorectal carcinomas
por: Koustas, Evangelos, et al.
Publicado: (2018)

The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors
por: Koustas, Evangelos, et al.
Publicado: (2020)

Are cystic fibrosis mutation carriers a potentially highly vulnerable group to COVID‐19?
por: Sarantis, Panagiotis, et al.
Publicado: (2020)

Pancreatic Cancer Prognosis, Malnutrition Risk, and Quality of Life: A Cross-Sectional Study
por: Poulia, Kalliopi-Anna, et al.
Publicado: (2022)

Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment?
por: Papadakos, Stavros P., et al.
Publicado: (2022)

The Clinical Impact of the EPH/Ephrin System in Cancer: Unwinding the Thread
por: Pergaris, Alexandros, et al.
Publicado: (2021)

The Interplay of Autophagy and Tumor Microenvironment in Colorectal Cancer—Ways of Enhancing Immunotherapy Action
por: Koustas, Evangelos, et al.
Publicado: (2019)

Inhibition of c‐MET increases the antitumour activity of PARP inhibitors in gastric cancer models
por: Koustas, Evangelos, et al.
Publicado: (2020)

The Role of the RANKL/RANK Axis in the Prevention and Treatment of Breast Cancer with Immune Checkpoint Inhibitors and Anti-RANKL
por: Simatou, Aristofania, et al.
Publicado: (2020)

Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy
por: Sarantis, Panagiotis, et al.
Publicado: (2020)

Liquid Biopsy: A New Translational Diagnostic and Monitoring Tool for Musculoskeletal Tumors
por: Hadjimichael, Argyris C., et al.
Publicado: (2021)

Role of Histone Deacetylases in the Pathogenesis of Salivary Gland Tumors and Therapeutic Targeting Options
por: Manou, Maria, et al.
Publicado: (2023)

Role of autophagy in cholangiocarcinoma: An autophagy-based treatment strategy
por: Koustas, Evangelos, et al.
Publicado: (2021)

The Clinical Impact of Death Domain-Associated Protein and Holliday Junction Recognition Protein Expression in Cancer: Unmasking the Driving Forces of Neoplasia
por: Pergaris, Alexandros, et al.
Publicado: (2023)

Predictive Biomarkers for Immune-Related Endocrinopathies following Immune Checkpoint Inhibitors Treatment
por: Shalit, Almog, et al.
Publicado: (2023)

Enhanced Transcriptional Signature and Expression of Histone-Modifying Enzymes in Salivary Gland Tumors
por: Manou, Maria, et al.
Publicado: (2023)

Resistance to hormone therapy in breast cancer cells promotes autophagy and EGFR signaling pathway
por: Siatis, Konstantinos E., et al.
Publicado: (2023)

The EPH/Ephrin System in Bone and Soft Tissue Sarcomas’ Pathogenesis and Therapy: New Advancements and a Literature Review
por: Hadjimichael, Argyris C., et al.
Publicado: (2022)

Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors
por: Sarantis, Panagiotis, et al.
Publicado: (2022)

Autophagy-related Proteins as a Prognostic Factor of Patients With Colorectal Cancer
por: Koustas, Evangelos, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pl0uoviq8qja93e6us2e0gst7l